Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1405818

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1405818

India Large Volume Parenteral Market Size, Share & Trends Analysis Report By Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), By Volume, By End-use, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

India Large Volume Parenteral Market Growth & Trends:

The India large volume parenteral market size is expected to reach USD 134.0 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. Large Volume Parenteral (LVP) injections are used for either total or partial nutrition when oral intake is insufficient or challenging. Earlier, these formulations were used for patients undergoing surgical procedures or those admitted to a hospital.

Currently, they are used as substitutes for nutrition obtained from a healthy diet. However, the demand for LVPs has significantly increased due to the growing adoption of parenteral nutrition over enteral nutrition among COVID-19 patients for improving drug absorption, shorter hospital stays, and reduced risk of infections. This is anticipated to drive the market over the forecast period.

In 2020, the nutritious injections application segment accounted for the largest revenue share. This is attributed to the growing adoption of these products in delivering intravenous carbohydrates, amino acids, electrolytes, and minerals to meet adequate nutritional requirements when enteral nutrition mode is insufficient, not possible, or contraindicated. On the other hand, the therapeutic injections segment is anticipated to register the fastest growth during the forecast period. The increasing prevalence of chronic conditions, such as cancer, can significantly impact the adoption of LVPs in the country, as they can provide vital nutrients to help maintain strength, energy, and hydration in patients from diagnosis to recovery.

In 2020, the 500 ml volume segment accounted for the largest revenue share. The increasing number of ICU admissions, rising demand for parenteral formulation among critically ill patients, growing preference for single-dose administration of vaccines and drugs, and increasing prevalence of various chronic disorders such as cancer and diabetes are some of the factors expected to propel this segment. On the other hand, the 100 ml volume segment is anticipated to register the fastest growth during the forecast period, as it can help avoid adverse effects related to nutrition and electrolyte imbalances.

In 2020, the hospital and other healthcare facilities segment dominated the market. The segment is anticipated to maintain its dominance during the forecast period. The growing prevalence of chronic conditions requiring dietary management in patients and increasing incidence of hospital-acquired malnutrition are expected to boost demand for LVPs. In addition, these formulations are administered preoperatively to reduce the rate of complications and hospital stay among surgical ICU patients. This is likely to increase the demand for LVPs among surgical and intensive care patients, thereby, propelling segment growth.

India Large Volume Parenteral Market Report Highlights:

  • The market is expected to grow well over the forecast period owing to high adoption rates of LVPs owing to growing physician preference for single-dose administration among critically ill patients
  • The nutritious injections application segment dominated the market in 2022, owing to the increasing adoption of these formulations to fulfill adequate nutritional requirements
  • The 500 ml volume segment dominated the market in 2022 owing to the increasing prevalence of chronic diseases such as cancer and CVDs
  • The hospital and other healthcare facilities end-use segment dominated the market in 2022 owing to an increase in the number of surgical procedures and rising prevalence of hospital-acquired malnutrition among patients
Product Code: GVR-2-68038-480-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Volume
    • 1.1.3. End use
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Volume outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. India Large Volume Parenteral Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. India Large Volume Parenteral Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. India Large Volume Parenteral Market: Application Estimates & Trend Analysis

  • 4.1. India Large Volume Parenteral Market: Key Takeaways
  • 4.2. India Large Volume Parenteral Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Therapeutic Injections
    • 4.3.1. Therapeutics injections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Fluid Balance Injections
    • 4.4.1. Fluid balance injections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Nutritious Injections
    • 4.5.1. Nutritious injections market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. India Large Volume Parenteral Market: Volume Estimates & Trend Analysis

  • 5.1. India Large Volume Parenteral Market: Key Takeaways
  • 5.2. India Large Volume Parenteral Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. 100 ml
    • 5.3.1. 100 ml market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. 250 ml
    • 5.4.1. 250 ml market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. 500 ml
    • 5.5.1. 500 ml market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. 1,000 ml
    • 5.6.1. 1000 ml market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. 2,000 ml
    • 5.7.1. 2,000 ml market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. India Large Volume Parenteral Market: End Use Estimates & Trend Analysis

  • 6.1. India Large Volume Parenteral Market: Key Takeaways
  • 6.2. India Large Volume Parenteral Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals and Other Healthcare Facilities
    • 6.3.1. Hospitals and other healthcare facilities market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Home Care
    • 6.4.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Market Categorization
    • 7.2.1. B. Braun SE
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Fresenius Kabi AG
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Baxter
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Otsuka Pharmaceutical Co., Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Sichuan Kelun
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Albert David Ltd.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. BML Parenteral Drugs
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
Product Code: GVR-2-68038-480-2

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 India large volume parenteral market, by application, 2018 - 2030 (USD Million)
  • Table 3 India large volume parenteral market, by volume, 2018 - 2030 (USD Million)
  • Table 4 India large volume parenteral market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 India Large Volume Parenteral: Market outlook
  • Fig. 9 India Large Volume Parenteral competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 India large volume parenteral market driver impact
  • Fig. 15 India large volume parenteral market restraint impact
  • Fig. 16 India large volume parenteral market strategic initiatives analysis
  • Fig. 17 India large volume parenteral market: Application movement analysis
  • Fig. 18 India large volume parenteral market: Application outlook and key takeaways
  • Fig. 19 Therapeutic injections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Fluid balance injections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Nutritious injections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 India Large Volume Parenteral market: Volume movement analysis
  • Fig. 23 India Large Volume Parenteral market: Volume outlook and key takeaways
  • Fig. 24 100 ml market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 250 ml market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 500 ml market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 1,000 ml market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 2,000 ml market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 India Large Volume Parenteral market: End use movement analysis
  • Fig. 30 India Large Volume Parenteral market: End use outlook and key takeaways
  • Fig. 31 Hospitals and other healthcare facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Home care market estimates and forecasts, 2018 - 2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!